Spotlight on biosimilars in oncology

Over the coming weeks on Oncology Central we will be carrying out a Spotlight event exploring the field of biosimilars in oncology. Join us as we look further into their development, evaluate the potential benefits alongside regulatory challenges and see whether there are sufficient resources available to clinicians who are considering adopting biosimilars.